Change the future of compounding pharmacy with us.

Functional Medicine

  1. September 17, 2024

    How Pharmacists Can Master Thyroid Conditions: Essential Steps and Resources

    Expanding Knowledge on Thyroid-Related Conditions

    Dr. Casey Greene, PharmD, IFMCP

    Nearly 20 million people in the US struggle with a thyroid-related condition, a significant stat that shows the magnitude of its reach across the population. And while compounding medications common to thyroid issues (such as T3/T4) are not new to the compounding world, there is a deep technical expertise required to develop such unique medications.

    No compounding pharmacy is created equal, so today’s compounding pharmacies determine if there are opportunities to enhance their thyroid expertise and how to communicate

    Read More
  2. September 17, 2024

    Compounding for Managing Thyroid Conditions

    Zoom Heaton PharmD., Women’s Health Clinical Liaison for Revelation Pharma

    Hashimoto’s disease, also known as Hashimoto’s thyroiditis and chronic lymphocytic thyroiditis, is a severe autoimmune disorder in which the immune system attacks the thyroid gland, affecting more women than men. If left alone, especially over an extended period of time, individuals can fall victim to serious complications that can lead to life-threatening hypothyroidism.

    With this, it’s crucial the medical community fosters a deep understanding of management options available to patients, specifically between conventional approaches and integrative functional approaches, and how a strategic blend between the two can result in a more substantial

    Read More
  3. April 12, 2024

    Patient Case: The Use of Methylene Blue in Canine Methemoglobinemia

    There's an interesting case study in the Journal of Veterinary Internal Medicine about a dog (juvenile, mixed breed) who presented with cyanosis, tachycardia, tachypnea, lethargy, exercise intolerance, and aggression when touched on the head.

    There's a lot going on there. To cut to the chase, a methylene blue IV administration (1 mg/kg) took care of the problem, which turned out to be a pair of gene mutations that led to reductase deficiency and then methemoglobinemia.

    The symptoms returned after 11 days, but a slightly higher dose of the methylene blue fixed the issue and now Fido (not his real name) gets that higher concentration every other day which keeps his methemoglobin concentration at bay.

    Methemoglobinemia can affect different animals differently, and while the solution seems

    Read More
  4. March 30, 2023

    Mayo Clinic review finds LDN can help with fibromyalgia

    A new study out of the Mayo Clinic (with a partner in South Korea) found that low-dose naltrexone seems both to work just great for combating the symptoms of fibromyalgia. It was already used off-label for that purpose, but the authors wanted to add a dose of science — to “systematically assess the current evidence.”

    Voila! In looking at the studies out there, they found that LDN helped manage the symptoms of fibromyalgia with “no severe adverse events were reported.”

    Read More